Pneumatic Retinopexy Versus Vitrectomy for Retinal Detachment in Patients With Extended Criteria
NCT ID: NCT02871531
Last Updated: 2019-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
178 participants
INTERVENTIONAL
2016-11-30
2023-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: A prospective, randomized, controlled trial will be conducted with 178 patients presenting at St. Michael's Hospital with primary retinal detachment (RD). Inclusion criteria include: a single or multiple retinal tears in detached retina between 7 and 5 o'clock being of any size and any distance apart from each other, including giant retinal tears with inferior aspect above 5 and 7 o'clock, RD with no identifiable tear but where suspected tear is between 7 and 5 o'clock, retinoschisis with RD if tears are located between 7 and 5 o'clock, mild proliferative vitreoretinopathy, none or mild vitreous hemorrhage. Patients will be excluded if there is a small retinal tear or multiple tears less than 30o apart between 8 and 4 o'clock in detached retina, retinal tear in detached retina between 5 and 7 o'clock, \<18 years old, inability to read English, mental incapacity, previous history of RD, scleral buckle or vitrectomy in index eye, inability to maintain appropriate head posture at post-operative period and inability to visualize peripheral retinal due to media opacity. Patients will be randomly allocated into two groups: PnR + cryotherapy/laser or vitrectomy + cryotherapy/laser and the intervention will take place within 24 hours and 72 hours for attached and detached macula status, respectively. Patients will undergo a complete ophthalmological examination, including visual acuity and fundus assessment at baseline and at 3, 6 and 12 months after surgery. Visual acuity will also be measured at 1, 7 and 30 days after surgery. Global health related quality of life will be evaluated with the SF-36v2 questionnaire at baseline, 1 month, 1 and 2 years after intervention, while the VFG25 questionnaire will be applied at 3, 6, 12 and 24 months after surgery to measure vision related quality of life.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pneumatic Retinopexy Versus Vitrectomy for Retinal Detachment
NCT01639209
Pneumatic Retinopexy for Primary Rhegmatogenous Retinal Detachment: To Steamroll or Not
NCT04723420
Retinal Displacement After Pneumatic Versus Vitrectomy for Retinal Detachment (ALIGN)
NCT04089033
Retinal Displacement Rates in Pneumatic Retinopexy Versus Pars Plana Vitrectomy For Primary Retinal Detachment
NCT04158622
Corneal Endothelial Cell Loss After Pneumatic Retinopexy for the Repair of Primary Rhegmatogenous Retinal Detachment
NCT02185469
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pneumatic retinopexy
Patients with retinal detachment allocated to pneumatic retinopexy
Pneumatic retinopexy
Vitrectomy
Patients with retinal detachment allocated to vitrectomy
Vitrectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pneumatic retinopexy
Vitrectomy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Retinal detachment with no identifiable tear but where suspected tear is located between 7-5 o'clock based on Lincoff rules
* Any size of retinal tear, including giant retinal tears, if the inferior aspect of it is above 5 and 7 o'clock
* Retinoschisis with retinal detachment if tears are located between 7 and 5 o'clock
* There may be mild proliferative vitreoretinopathy (unless there is a visible traction on the break)
* None or mild vitreous hemorrhage. Note: vitreous hemorrhage will be considered mild if it does not impair an adequate examination of the retinal periphery.
* In the opinion of the investigator, PnR is likely to achieve anatomical re-attachment of the retina
Exclusion Criteria
* Single retinal tear smaller than 1 o'clock in detached retina between 8-4 o'clock
* Retinal tears below the 5 and 7 o'clock meridian in detached retina (note that additional tears in attached retina are acceptable)
* Inability to read English language
* Age \<18 years
* Mental incapacity
* Previous vitrectomy or scleral buckle (index eye)
* Previous retinal detachment (index eye)
* Inability to maintain the strict post-operative posturing requirements of pneumatic retinopexy
* Inability to carry out detailed examination of the peripheral retina due to media opacity NOTE: Lens/posterior hyaloid status does not affect eligibility.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Unity Health Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rajeev Muni, FRSCS
Role: PRINCIPAL_INVESTIGATOR
staff
Verena Juncal, MD
Role: PRINCIPAL_INVESTIGATOR
research fellow
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Michael's Hospital Eye Clinic
Toronto, Ontario, Canada
Sunnybrook Health Sciences Centre
Toronto, , Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Rajeev Muni, MD Msc FRCSC
Role: primary
Peter Kertes
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Extended criteria pneumaticPPV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.